Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Saeid Najafi-Fard

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

100%

Immunology

100%

Covid-19

60%

Sars-cov-2

60%

Immune Response

50%

Diagnostic Assay

30%

Antiviral Research

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Evaluation of the Local and Peripheral Immune Responses in Patients with Cystic Echinococcosis

Article Link

Year:

2024

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection

Article Link

Year:

2023

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

Article Link

Year:

2023

Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis

Article Link

Year:

2023

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

Article Link

Year:

2022

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy

Article Link

Year:

2022

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy

Article Link

Year:

2021

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients

Article Link

Year:

2021

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients

Article Link

Year:

2021

Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts

Article Link

Year:

2021

Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy

Article Link

Year:

2021

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection

Article Link

Year:

2021

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients

Article Link

Year:

2021

Impact of prior influenza and pneumoccocal vaccines on humoral and cellular response to sars-cov-2 bnt162b2 vaccination

Article Link

Year:

2021

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses

Article Link

Year:

2021

Collaborators5

Massimo Francalancia

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

ITALY

Sara Leone

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

ITALY

Federica Rossin

University of Rome Tor Vergata

ITALY

Roberta Nardacci

Professore Associato (BIO-13)

Saint Camillus International University of Health Sciences

ITALY

Alessandro Sette

Professor and Member

La Jolla Institute for Immunology

UNITED STATES

How do I reach out?

Meet Kite AI